Search - tctmd.com

Displaying 141 - 160 of 839

Sort: Relevancy | Date

Presentation THT 2024

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Presenter: Van-Khue Ton

March 04, 2024

Presentation THT Abstracts 2024

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Presenter: James Schurr

March 04, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation Miami Valves 2024

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Presenter: Miguel Martillo Correa

February 03, 2024

Presentation Miami Valves 2024

National Cardiogenic Shock Initiative: What we’ve learned?

Presenter: Alejandro Lemor

February 03, 2024

Presentation Miami Valves 2024

Lessons Learned & Best Practices in Cardiogenic Shock

Presenter: Abdulla A. Damluji

February 01, 2024

Presentation Miami Valves 2024

Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock

Presenter: Victor Razuk

February 01, 2024

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

Presentation TCT 2023

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Presenter: Jennifer Rymer

October 26, 2023

Presentation TCT 2023

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

Presenter: Babar Basir

October 26, 2023

Advertisement

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Cardiogenic Shock: The Case for Feasibility and Recovery

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Acute Myocardial Infarction Complicated with Cardiogenic Shock

National Cardiogenic Shock Initiative: What we’ve learned?

Lessons Learned & Best Practices in Cardiogenic Shock

Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock

November 2023 News Roundup

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content